{"id":"W1981574714","doi":"10.1007/s00415-011-6275-7","title":"Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS","year":2011,"lang":"en","type":"article","venue":"Journal of Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. Michael's Hospital","funders":"IC Design Education Center; Bayer HealthCare; Biogen","keywords":"Natalizumab; Expanded Disability Status Scale; Medicine; Multiple sclerosis; Placebo; Internal medicine; Neurology; Clinical endpoint; Clinical trial; Immunology; Pathology; Psychiatry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01837786,0.002674739,0.004273659,0.00172597,0.000933686,0.001684248,0.0009949484,0.001186034,0.006028369],"category_scores_gemma":[0.01340718,0.0003954598,0.006816316,0.001586812,0.0006471367,0.001876352,0.001057709,0.003136067,0.0008001831],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001038019,"about_ca_system_score_gemma":0.001382069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006345604,"about_ca_topic_score_gemma":0.002099486,"domain_scores_codex":[0.9902755,0.006560518,0.001131933,0.0005521324,0.000946823,0.0005329823],"domain_scores_gemma":[0.9845092,0.008195331,0.00354869,0.001210655,0.001359004,0.001177076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8215765,0.003575109,0.01528843,0.008877261,0.02456091,0.0002583249,0.0002999906,0.002959545,0.009826251,0.0007791681,0.009123791,0.1028747],"study_design_scores_gemma":[0.3108052,0.2536769,0.2888848,0.002180563,0.07186259,0.001244849,0.0004207587,0.00246419,0.0139001,0.004996807,0.04925723,0.000305987],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8415855,0.09472329,0.003919805,0.002655875,0.001079643,0.004046251,0.03240651,0.0002306603,0.01935245],"genre_scores_gemma":[0.9714454,0.007227586,0.001671741,0.001038655,0.0009200104,0.001790761,0.01392951,0.00005374283,0.001922609],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01837786,"threshold_uncertainty_score":0.09719265,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1736209135993706,"score_gpt":0.3586830282784313,"score_spread":0.1850621146790607,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}